{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:11:18Z","timestamp":1791443478510,"version":"4.3.3"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bausch & Lomb Incorporated"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0205814","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T17:40:45Z","timestamp":1539884445000},"page":"e0205814","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study"],"prefix":"10.1371","volume":"13","author":[{"given":"Penny A.","family":"Asbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-6896","authenticated-orcid":true,"given":"Heleen H.","family":"DeCory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"ref1","unstructured":"American Academy of Ophthalmology Cornea\/External Disease Panel. Preferred Practice Pattern\u00ae Guidelines. Conjunctivitis. San Francisco, CA: American Academy of Ophthalmology; 2013. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.aao.org\/preferred-practice-pattern\/conjunctivitis-ppp\u20142013\" xlink:type=\"simple\">https:\/\/www.aao.org\/preferred-practice-pattern\/conjunctivitis-ppp\u20142013<\/ext-link>. Accessed January 16, 2017."},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jama.2013.280318","article-title":"Conjunctivitis: A systematic review of diagnosis and treatment","volume":"310","author":"AA Azari","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"G H\u00f8vding","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-010-1426-6","article-title":"Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary","volume":"249","author":"A Adebayo","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref5","first-page":"704","article-title":"Bacterial conjunctivitis. BMJ Clin Evid","volume":"2012","author":"J Epling","year":"2012","journal-title":"Bacterial conjunctivitis. BMJ Clin Evid"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.emc.2007.10.004","article-title":"Ocular infection and inflammation","volume":"26","author":"JB Mueller","year":"2008","journal-title":"Emerg Med Clin N Am"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaapos.2017.08.008","article-title":"Patient demographic and microbiology trends in bacterial conjunctivitis in children","volume":"22","author":"FV Chen","year":"2018","journal-title":"J AAPOS"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1197\/j.aem.2006.08.006","article-title":"Clinical features of bacterial conjunctivitis in children","volume":"14","author":"PB Patel","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"7563","key":"ref9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.38891.551088.7C","article-title":"A randomized controlled trial of management strategies for acute infective conjunctivitis in general practice","volume":"333","author":"HA Everitt","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11534380-000000000-00000","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: A post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials","volume":"12","author":"TL Comstock","year":"2010","journal-title":"Pediatr Drugs"},{"key":"ref11","first-page":"CD001211","article-title":"Antibiotics versus placebo for acute bacterial conjunctivitis","volume":"9","author":"A Sheikh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinthera.2010.12.004","article-title":"Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children","volume":"33","author":"BE Silverstein","year":"2011","journal-title":"Clin Ther"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3928\/01913913-20070301-03","article-title":"Exclusion of students with conjunctivitis from school: policies of state departments of health","volume":"44","author":"CM Ohnsman","year":"2007","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"ref14","first-page":"2009","article-title":"Ocular TRUST 3: ongoing longitudinal surveillance of antimicrobial susceptibility in ocular isolates","volume":"7","author":"PA Asbell","journal-title":"American Society of Cataract and Refractive Surgery Annual Meeting"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","article-title":"Antibiotic resistance among ocular pathogens in the United States: Five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study","volume":"133","author":"PA Asbell","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: Results from the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) 2009 surveillance study","volume":"152","author":"W Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jcrs.2010.06.028","article-title":"Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones","volume":"36","author":"M McDonald","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/OPTH.S5778","article-title":"Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics","volume":"3","author":"JS Jr Bertino","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ophtha.2014.06.049","article-title":"Antibiotic resistance in acute postoperative endophthalmitis","volume":"121","author":"EJ Holland","year":"2014","journal-title":"Ophthalmology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ICO.0000000000000352","article-title":"Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania","volume":"34","author":"N Ni","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/0255-0857.83903","article-title":"Antibiotic resistance in ocular bacterial pathogens","volume":"29","author":"S Sharma","year":"2011","journal-title":"Indian J Med Microbiol"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","article-title":"Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review","volume":"121","author":"RC Gentile","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","article-title":"Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-Year Review","volume":"34","author":"VS Chang","year":"2015","journal-title":"Cornea"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/AAC.44.6.1650-1654.2000","article-title":"Increasing bacterial resistance in pediatric acute conjunctivitis (1997\u20131998)","volume":"44","author":"SL Block","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ophtha.2011.03.017","article-title":"Ophthalmic antibiotic use and multidrug-resistant Staphylococcus epidermidis: A controlled, longitudinal study.","volume":"118","author":"SB Dave","year":"2011","journal-title":"Ophthalmology"},{"key":"ref26","first-page":"243","article-title":"Trends in ocular manifestations of methicillin-resistant Staphylococcus aureus (MRSA) in a northern California pediatric population","volume":"17","author":"M Amato","year":"2013","journal-title":"JAAPOS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.121.9.1229","article-title":"Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis","volume":"121","author":"KR Wilhelmus","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","article-title":"Ciprofloxacin-resistant Pseudomonas keratitis","volume":"106","author":"P Garg","year":"1999","journal-title":"Ophthalmology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcrs.2005.12.108","article-title":"Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery","volume":"32","author":"M Moshirfar","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0301-4738.179721","article-title":"Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate","volume":"64","author":"S Chatterjee","year":"2016","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2007.03.076","article-title":"Update on bacterial conjunctivitis in south Florida","volume":"115","author":"K Cavuoto","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: Nationwide antimicrobial susceptibility patterns in ocular isolates","volume":"145","author":"PA Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"ref33","first-page":"2008","article-title":"Longitudinal nationwide antimicrobial susceptibility surveillance in ocular isolates: results for Ocular TRUST 2","volume":"28","author":"PA Asbell","journal-title":"American Society of Cataract and Refractive Surgery Annual Meeting"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17925\/USOR.2017.10.01.35","article-title":"Antibiotic resistance trends among ocular pathogens in the US\u2014Cumulative results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study","volume":"10","author":"PA Asbell","year":"2017","journal-title":"US Ophthalmic Review"},{"key":"ref35","year":"2009"},{"key":"ref36","year":"2012"},{"key":"ref37","year":"2015"},{"key":"ref38","year":"2009"},{"key":"ref39","year":"2009"},{"key":"ref40","year":"2009"},{"key":"ref41","year":"2009"},{"key":"ref42","year":"2009"},{"key":"ref43","year":"2009"},{"key":"ref44","year":"2009"},{"key":"ref45","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2009"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2307\/3001913","article-title":"Comparing individual means in the analysis of variance","volume":"5","author":"J Tukey","year":"1949","journal-title":"Biometrics"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies","volume":"11","author":"P Armitage","year":"1955","journal-title":"Biometrics"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2010.02.030","article-title":"Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections","volume":"117","author":"JM Moss","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ajo.2012.06.024","article-title":"Ocular flora and their antibiotic resistance patterns in the midwest: A prospective study of patients undergoing cataract surgery.","volume":"155","author":"HY Hsu","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.clinthera.2009.03.010","article-title":"Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5- day efficacy and safety study","volume":"31","author":"P Karpecki","year":"2009","journal-title":"Clin Ther"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1185\/03007990902837919","article-title":"Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis","volume":"25","author":"ME Tepedino","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2009.05.014","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis","volume":"116","author":"MB McDonald","year":"2009","journal-title":"Ophthalmology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40268-013-0029-1","article-title":"The safety of besifloxacin ophthalmic suspension 0.6% used three times daily for 7 days in the treatment of bacterial conjunctivitis","volume":"13","author":"R Malhotra","year":"2013","journal-title":"Drugs R D"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11632470-000000000-00000","article-title":"Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children","volume":"32","author":"J DeLeon","year":"2012","journal-title":"Clin Drug Investig"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/OPTH.S23518","article-title":"Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes","volume":"5","author":"TW Morris","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"ref56","year":"2016"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/OPTH.S14333","article-title":"Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery","volume":"4","author":"R Olson","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2005.06.025","article-title":"An ophthalmologist&apos;s guide to understanding antibiotic susceptibility and minimum Inhibitory concentration data","volume":"112","author":"RP Kowalski","year":"2005","journal-title":"Ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0205814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T12:24:25Z","timestamp":1605270265000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0205814"}},"subtitle":[],"editor":[{"given":"Massimiliano","family":"Galdiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":58,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0205814","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]}}}